Table of Contents
1. Executive summary
2. Market Introduction
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. Research Methodology
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Modality
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. Market Dynamics
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. Market Factor Analysis
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL Uterine Fibroid Treatment Device MARKET, BY Technology
6.1. Overview
6.2. Surgical Techniques
6.3. Laparoscopic Techniques
6.4. Ablation Techniques
6.5. Embolization Techniques
7. GLOBAL Uterine Fibroid Treatment Device MARKET, BY Mode of Treatment
7.1. Overview
7.2. Invasive Treatment
7.3. Minimally Invasive Treatment
7.4. Non-invasive Treatment
8. GLOBAL Uterine Fibroid Treatment Device MARKET, by Region
8.1. Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K
8.3.4. Italy
8.3.5. Spain
8.3.6. Rest of Europe
8.4. Asia-Pacific
8.4.1. China
8.4.2. India
8.4.3. Japan
8.4.4. South Korea
8.4.5. Australia
8.4.6. Rest of Asia-Pacific
8.5. Rest of the World
8.5.1. Middle East
8.5.2. Africa
8.5.3. Latin America
9. Competitive Landscape
9.1. Overview
9.2. Competitive Analysis
9.3. Market Share Analysis
9.4. Major Growth Strategy in the Global Uterine Fibroid Treatment Device Market,
9.5. Competitive Benchmarking
9.6. Leading Players in Terms of Number of Developments in the Global Uterine Fibroid Treatment Device Market,
9.7. Key developments and Growth Strategies
9.7.1. New TECHNOLOGY Launch/Mode of Treatment Deployment
9.7.2. Merger & Acquisitions
9.7.3. Joint Ventures
9.8. Major Players Financial Matrix
9.8.1. Sales & Operating Income, 2022
9.8.2. Major Players R&D Expenditure. 2022
10. Company ProfileS
10.1. Medtronic
10.1.1. Company Overview
10.1.2. Financial Overview
10.1.3. Technology Offered
10.1.4. Key Developments
10.1.5. SWOT Analysis
10.1.6. Key Strategies
10.2. Stryker Corporation
10.2.1. Company Overview
10.2.2. Financial Overview
10.2.3. Technology Offered
10.2.4. Key Developments
10.2.5. SWOT Analysis
10.2.6. Key Strategies
10.3. CooperSurgical Inc.
10.3.1. Company Overview
10.3.2. Financial Overview
10.3.3. Technology Offered
10.3.4. Key Developments
10.3.5. SWOT Analysis
10.3.6. Key Strategies
10.4. Ethicon, Inc.
10.4.1. Company Overview
10.4.2. Financial Overview
10.4.3. Technology Offered
10.4.4. Key Developments
10.4.5. SWOT Analysis
10.4.6. Key Strategies
10.5. Hologic, Inc.
10.5.1. Company Overview
10.5.2. Financial Overview
10.5.3. Technology Offered
10.5.4. Key Developments
10.5.5. SWOT Analysis
10.5.6. Key Strategies
10.6. Minerva Surgical, Inc.
10.6.1. Company Overview
10.6.2. Financial Overview
10.6.3. Technology Offered
10.6.4. Key Developments
10.6.5. SWOT Analysis
10.6.6. Key Strategies
10.7. Lumenis
10.7.1. Company Overview
10.7.2. Financial Overview
10.7.3. Technology Offered
10.7.4. Key Developments
10.7.5. SWOT Analysis
10.7.6. Key Strategies
10.8. Boston scientific
10.8.1. Company Overview
10.8.2. Financial Overview
10.8.3. Technology Offered
10.8.4. Key Developments
10.8.5. SWOT Analysis
10.8.6. Key Strategies
10.9. INSIGHTEC
10.9.1. Company Overview
10.9.2. Financial Overview
10.9.3. Technology Offered
10.9.4. Key Developments
10.9.5. SWOT Analysis
10.9.6. Key Strategies
10.10. Karl Storz GmbH
10.10.1. Company Overview
10.10.2. Financial Overview
10.10.3. Technology Offered
10.10.4. Key Developments
10.10.5. SWOT Analysis
10.10.6. Key Strategies
11. Appendix
11.1. References
11.2. Related Reports
LIST OF TABLES
TABLE 1 Global Uterine Fibroid Treatment Device Market, Synopsis, 2018-2032
TABLE 2 Global Uterine Fibroid Treatment Device Market, Estimates & Forecast, 2018-2032 (USD BILLION)
TABLE 3 GLOBAL Uterine Fibroid Treatment Device MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 4 GLOBAL Uterine Fibroid Treatment Device MARKET, BY MODE OF TREATMENT, 2018-2032 (USD BILLION)
TABLE 5 North America Uterine Fibroid Treatment Device MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 6 North America Uterine Fibroid Treatment Device MARKET, BY MODE OF TREATMENT, 2018-2032 (USD BILLION)
TABLE 7 North America Uterine Fibroid Treatment Device MARKET, BY Country, 2018-2032 (USD BILLION)
TABLE 8 U.S. Uterine Fibroid Treatment Device MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 9 U.S. Uterine Fibroid Treatment Device MARKET, BY MODE OF TREATMENT, 2018-2032 (USD BILLION)
TABLE 10 Canada Uterine Fibroid Treatment Device MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 11 Canada Uterine Fibroid Treatment Device MARKET, BY MODE OF TREATMENT, 2018-2032 (USD BILLION)
TABLE 12 Europe Uterine Fibroid Treatment Device MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 13 Europe Uterine Fibroid Treatment Device MARKET, BY MODE OF TREATMENT, 2018-2032 (USD BILLION)
TABLE 14 Europe Uterine Fibroid Treatment Device MARKET, BY Country, 2018-2032 (USD BILLION)
TABLE 15 Germany Uterine Fibroid Treatment Device MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 16 Germany Uterine Fibroid Treatment Device MARKET, BY MODE OF TREATMENT, 2018-2032 (USD BILLION)
TABLE 17 France Uterine Fibroid Treatment Device MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 18 France Uterine Fibroid Treatment Device MARKET, BY MODE OF TREATMENT, 2018-2032 (USD BILLION)
TABLE 19 Italy Uterine Fibroid Treatment Device MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 20 Italy Uterine Fibroid Treatment Device MARKET, BY MODE OF TREATMENT, 2018-2032 (USD BILLION)
TABLE 21 Spain Uterine Fibroid Treatment Device MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 22 Spain Uterine Fibroid Treatment Device MARKET, BY MODE OF TREATMENT, 2018-2032 (USD BILLION)
TABLE 23 U.K Uterine Fibroid Treatment Device MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 24 U.K Uterine Fibroid Treatment Device MARKET, BY MODE OF TREATMENT, 2018-2032 (USD BILLION)
TABLE 25 Rest of Europe Uterine Fibroid Treatment Device MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 26 Rest of Europe Uterine Fibroid Treatment Device MARKET, BY MODE OF TREATMENT, 2018-2032 (USD BILLION)
TABLE 27 Asia Pacific Uterine Fibroid Treatment Device MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 28 Asia Pacific Uterine Fibroid Treatment Device MARKET, BY MODE OF TREATMENT, 2018-2032 (USD BILLION)
TABLE 29 Asia Pacific Uterine Fibroid Treatment Device MARKET, BY Country, 2018-2032 (USD BILLION)
TABLE 30 Japan Uterine Fibroid Treatment Device MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 31 Japan Uterine Fibroid Treatment Device MARKET, BY MODE OF TREATMENT, 2018-2032 (USD BILLION)
TABLE 32 China Uterine Fibroid Treatment Device MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 33 China Uterine Fibroid Treatment Device MARKET, BY MODE OF TREATMENT, 2018-2032 (USD BILLION)
TABLE 34 India Uterine Fibroid Treatment Device MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 35 India Uterine Fibroid Treatment Device MARKET, BY MODE OF TREATMENT, 2018-2032 (USD BILLION)
TABLE 36 Australia Uterine Fibroid Treatment Device MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 37 Australia Uterine Fibroid Treatment Device MARKET, BY MODE OF TREATMENT, 2018-2032 (USD BILLION)
TABLE 38 south korea Uterine Fibroid Treatment Device MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 39 south korea Uterine Fibroid Treatment Device MARKET, BY MODE OF TREATMENT, 2018-2032 (USD BILLION)
TABLE 40 Rest of asia-pacific Uterine Fibroid Treatment Device MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 41 Rest of asia-pacific Uterine Fibroid Treatment Device MARKET, BY MODE OF TREATMENT, 2018-2032 (USD BILLION)
TABLE 42 Rest of WOrld Uterine Fibroid Treatment Device MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 43 Rest of WOrld Uterine Fibroid Treatment Device MARKET, BY MODE OF TREATMENT, 2018-2032 (USD BILLION)
TABLE 44 Rest of WOrld Uterine Fibroid Treatment Device MARKET, BY Country, 2018-2032 (USD BILLION)
TABLE 45 Middle east Uterine Fibroid Treatment Device MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 46 Middle east Uterine Fibroid Treatment Device MARKET, BY MODE OF TREATMENT, 2018-2032 (USD BILLION)
TABLE 47 Africa Uterine Fibroid Treatment Device MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 48 Africa Uterine Fibroid Treatment Device MARKET, BY MODE OF TREATMENT, 2018-2032 (USD BILLION)
TABLE 49 Latin america Uterine Fibroid Treatment Device MARKET, BY TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 50 Latin america Uterine Fibroid Treatment Device MARKET, BY MODE OF TREATMENT, 2018-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 Research Process
FIGURE 2 Market Structure for the Global Uterine Fibroid Treatment Device Market
FIGURE 3 Market Dynamics for the Global Uterine Fibroid Treatment Device Market
FIGURE 4 Global Uterine Fibroid Treatment Device Market, Share (%), BY TECHNOLOGY, 2022
FIGURE 5 Global Uterine Fibroid Treatment Device Market, Share (%), BY MODE OF TREATMENT, 2022
FIGURE 6 Global Uterine Fibroid Treatment Device Market, Share (%), by Region, 2022
FIGURE 7 north AMERICA: Uterine Fibroid Treatment Device MARKET, SHARE (%), BY REGION, 2022
FIGURE 8 Europe: Uterine Fibroid Treatment Device MARKET, SHARE (%), BY REGION, 2022
FIGURE 9 Asia-Pacific: Uterine Fibroid Treatment Device MARKET, SHARE (%), BY REGION, 2022
FIGURE 10 Rest of the world: Uterine Fibroid Treatment Device MARKET, SHARE (%), BY REGION, 2022
FIGURE 11 Global Uterine Fibroid Treatment Device Market: Company Share Analysis, 2022 (%)
FIGURE 12 Medtronic: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 13 Medtronic: SWOT ANALYSIS
FIGURE 14 Stryker Corporation: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 Stryker Corporation: SWOT ANALYSIS
FIGURE 16 CooperSurgical Inc.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 CooperSurgical Inc.: SWOT ANALYSIS
FIGURE 18 Ethicon, Inc.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 Ethicon, Inc.: SWOT ANALYSIS
FIGURE 20 Hologic, Inc..: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 Hologic, Inc..: SWOT ANALYSIS
FIGURE 22 Minerva Surgical, Inc.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 Minerva Surgical, Inc.: SWOT ANALYSIS
FIGURE 24 Lumenis: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 Lumenis: SWOT ANALYSIS
FIGURE 26 Boston scientific: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 Boston scientific: SWOT ANALYSIS
FIGURE 28 INSIGHTEC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 INSIGHTEC: SWOT ANALYSIS
FIGURE 30 Karl Storz GmbH: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 Karl Storz GmbH: SWOT ANALYSIS